UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
(Exact Name of Registrant as Specified in its Charter) |
(State or Other Jurisdiction |
(Commission File Number) |
(IRS Employer |
(Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including
area code: (
N/A |
(Former Name or Former Address, if Changed Since Last Report.) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of exchange on which registered | ||
N/A |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
Item 3.02. Unregistered Sales of Securities
On October 31, 2022, Western Uranium & Vanadium Corp. (“Western” or the “Company”) granted an aggregate of 1,665,000 stock options to purchase common shares to officers, directors, and employees of Western under the Company’s Incentive Stock Option Plan. The options have an exercise price of CAD$1.60, and each option is exercisable to acquire one common share for a five-year term commencing on the applicable vesting date. The options vest in two equal installments beginning on the date of grant and thereafter on April 30, 2023.
The Company granted the options in reliance on the private offering exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
On November 2, 2022, the Company issued the following press release.
Exhibit No. | Description | |
99.1 | Press release dated November 2, 2022 | |
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: November 2, 2022 | WESTERN URANIUM & VANADIUM CORP. | |
By: | /s/ Robert Klein | |
Robert Klein Chief Financial Officer |
2